Holen Sie sich die Stockscreener-App
420.74
0.67%
-2.82
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$423.56
Offen:
$425.24
24-Stunden-Volumen:
3.75M
Relative Volume:
0.53
Marktkapitalisierung:
$382.09B
Einnahmen:
$450.13B
Nettoeinkommen (Verlust:
$14.91B
KGV:
27.06
EPS:
15.551
Netto-Cashflow:
$23.62B
1W Leistung:
-1.26%
1M Leistung:
+3.68%
6M Leistung:
+18.10%
1J Leistung:
+51.03%
1-Tages-Spanne:
$418.92
$429.00
1-Wochen-Bereich:
$417.38
$437.00
52-Wochen-Spanne:
$234.60
$461.62
Unitedhealth Group Inc Stock (UNH) Company Profile
Firmenname
Unitedhealth Group Inc
Sektor
Branche
Telefon
1-800-328-5979
Adresse
1 HEALTH DRIVE, EDEN PRAIRIE
Compare UNH vs CVS, ELV, CI, HUM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
UNH
Unitedhealth Group Inc
|
420.74 | 382.09B | 450.13B | 14.91B | 23.62B | 15.55 |
CVS
Cvs Health Corp
|
107.74 | 137.47B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
377.68 | 81.91B | 201.11B | 4.95B | 6.29B | 22.50 |
CI
Cigna Group
|
289.57 | 76.60B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
389.32 | 46.74B | 137.20B | 1.15B | 1.27B | 9.3439 |
Unitedhealth Group Inc Stock (UNH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-06-04 | Hochstufung | BofA Securities | Neutral → Buy |
| 2026-04-27 | Hochstufung | Erste Group | Hold → Buy |
| 2026-04-22 | Hochstufung | Argus | Hold → Buy |
| 2026-04-07 | Hochstufung | HSBC Securities | Reduce → Hold |
| 2026-04-01 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2025-10-29 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-10-14 | Eingeleitet | Goldman | Buy |
| 2025-07-31 | Herabstufung | Robert W. Baird | Neutral → Underperform |
| 2025-07-30 | Bestätigt | Oppenheimer | Outperform |
| 2025-06-11 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-05-21 | Herabstufung | HSBC Securities | Hold → Reduce |
| 2025-05-19 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-05-14 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-05-14 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2025-04-22 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-04-21 | Herabstufung | Argus | Buy → Hold |
| 2025-01-10 | Hochstufung | HSBC Securities | Hold → Buy |
| 2025-01-06 | Bestätigt | Truist | Buy |
| 2024-10-17 | Herabstufung | HSBC Securities | Buy → Hold |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-07-17 | Hochstufung | Jefferies | Hold → Buy |
| 2024-07-17 | Bestätigt | RBC Capital Mkts | Outperform |
| 2024-06-05 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-04-04 | Hochstufung | HSBC Securities | Reduce → Hold |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2023-12-18 | Herabstufung | HSBC Securities | Hold → Reduce |
| 2023-10-16 | Hochstufung | UBS | Neutral → Buy |
| 2023-09-06 | Eingeleitet | HSBC Securities | Hold |
| 2023-07-19 | Bestätigt | UBS | Neutral |
| 2023-07-18 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2023-07-17 | Bestätigt | JP Morgan | Overweight |
| 2023-07-17 | Bestätigt | RBC Capital Mkts | Outperform |
| 2023-07-17 | Bestätigt | TD Cowen | Outperform |
| 2023-05-26 | Eingeleitet | Piper Sandler | Overweight |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-04-05 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2022-11-23 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-11-21 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2021-12-14 | Eingeleitet | Goldman | Buy |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Buy |
| 2021-06-01 | Bestätigt | BofA Securities | Buy |
| 2021-05-19 | Eingeleitet | Wells Fargo | Overweight |
| 2021-04-21 | Hochstufung | Argus | Hold → Buy |
| 2020-10-19 | Herabstufung | Argus | Buy → Hold |
| 2020-07-01 | Fortgesetzt | SVB Leerink | Outperform |
| 2020-06-05 | Eingeleitet | Goldman | Buy |
| 2020-03-20 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2019-10-18 | Eingeleitet | Mizuho | Buy |
| 2019-10-10 | Herabstufung | Jefferies | Buy → Hold |
| 2019-09-30 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Hold |
| 2019-05-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2019-04-23 | Eingeleitet | UBS | Neutral |
| 2019-04-17 | Bestätigt | BofA/Merrill | Buy |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2018-09-10 | Herabstufung | Citigroup | Buy → Neutral |
| 2018-06-11 | Eingeleitet | SunTrust | Buy |
| 2018-03-08 | Eingeleitet | Barclays | Overweight |
| 2018-01-17 | Bestätigt | Citigroup | Buy |
| 2018-01-12 | Bestätigt | Evercore ISI | Outperform |
| 2018-01-03 | Eingeleitet | Goldman | Buy |
| 2017-07-19 | Bestätigt | Mizuho | Buy |
| 2017-06-07 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Unitedhealth Group Inc Aktie (UNH) Neueste Nachrichten
UnitedHealth Group stock holds near recent highs as Medicare strength offsets cyberattack costs - AD HOC NEWS
UnitedHealth Group stock steadies as Q2 2026 results highlight growth and Medicare changes - AD HOC NEWS
The Real Price of UnitedHealth Stock Is Two Years Away - Trefis
Is Trending Stock UnitedHealth Group Incorporated (UNH) a Buy Now? - Yahoo Finance
UnitedHealth Group stock steadies as Medicare and Optum growth support outlook after Q2 earnings mis - AD HOC NEWS
UnitedHealth Group stock holds as earnings and guidance stay central - Ad-hoc-news.de
UnitedHealth's $5M Demand Challenged By Wash. Dental Co. - Law360
UnitedHealth’s earnings comeback hides a risk Wall Street can’t price - thestreet.com
UnitedHealth Group stock steadies as higher 2024 guidance follows strong Optum growth - Ad-hoc-news.de
Judge Throws Out UnitedHealth's Defamation Lawsuit Against The Guardian - HEALTH CARE un-covered
UnitedHealth Just Beat Estimates by 30%. Wall Street Wants More. - TIKR.com
Did Strong Q2 Results and Buybacks Just Shift UnitedHealth Group's (UNH) Investment Narrative? - simplywall.st
CNBC ‘Final Trades’: UnitedHealth, Nvidia And MoreUnitedHealth Group (NYSE:UNH) - Benzinga
UnitedHealth Group stock steadies as Q2 2026 earnings and Optum growth frame outlook - Ad-hoc-news.de
UnitedHealth Group | History, Growth, & Controversies | Britannica Money - Encyclopedia Britannica
UnitedHealth Group (NYSE:UNH) In Focus After Lifting Full-Year View - Kalkine Media
UnitedHealth Group stock steadies as Optum revenue drives earnings resilience - Ad-hoc-news.de
Will UnitedHealth (UNH) Gain on Rising Earnings Estimates? - Yahoo Finance
UnitedHealth Group (NYSE:UNH): Is the Recovery Fully Priced In? - Kalkine Media
UnitedHealth's defamation suit against The Guardian dismissed - BenefitsPRO
UnitedHealth Group (UNH) Hits New 52-Week High Amid S&P 500 Surge - GuruFocus
UnitedHealth: Recovery Unlikely To Be LinearNear-Term Consolidation Risks (NYSE:UNH) - Seeking Alpha
Nvidia, Goldman Sachs, UnitedHealth and an Energy Stock on CNBC’s ‘Final Trades’ - Benzinga
UnitedHealth Group stock stabilizes after Q2 earnings highlight resilient insurance and Optum growth - Ad-hoc-news.de
UnitedHealth (UNH) Stock Still Looks Like A Bargain As Forecasts Rise - simplywall.st
UnitedHealth Group Inc (UNH) Stock Up 3.5% and Still Undervalued -- GF Score: 86/100 - GuruFocus
UnitedHealth Group stock trades steady as Q2 2026 earnings highlight resilient growth and Medicare l - Ad-hoc-news.de
What Kept Coming Up When Analysts Grilled UNH - Trefis
UnitedHealth Group (NYSE:UNH) in Focus After Lifting Full-Year Guidance - Kalkine Media
Delaware judge dismisses UnitedHealth Group lawsuit against the Guardian - The Guardian
UnitedHealth Group stock steadies as strong Q2 2026 earnings and Optum growth underpin outlook - Ad-hoc-news.de
Unitedhealth Group Inc Stock (UNH) Moved Up by 3.02% on Jul 21: Drivers Behind the Movement - TradingKey
UnitedHealth Helped Write the Law It Now Blames for Your Rising Premiums - HEALTH CARE un-covered
UNH Maintained by JP Morgan -- Price Target Raised to $516 - GuruFocus
All You Need to Know About UnitedHealth (UNH) Rating Upgrade to Strong Buy - Yahoo Finance
UnitedHealth: The Cure For The AI Blues (NYSE:UNH) - Seeking Alpha
Bernstein raises UnitedHealth stock price target on MA recovery - Investing.com
3M, UnitedHealth Share Gains Contribute To Dow's 150-Point Climb - 富途牛牛
UnitedHealth Stock: Is It Headed for $500? - The Motley Fool
UnitedHealth Group stock holds gains as earnings and membership growth underpin valuation - Ad-hoc-news.de
JPMorgan Adjusts Price Target on UnitedHealth Group to $516 From $466, Maintains Overweight Rating - marketscreener.com
Mizuho Adjusts Price Target on UnitedHealth Group to $493 From $470, Maintains Outperform Rating - marketscreener.com
UnitedHealth Group (NYSE:UNH) Expands S&P 500 Healthcare Reach - Kalkine Media
UnitedHealth Group stock steadies after Q2 2026 earnings highlight managed care strength - Ad-hoc-news.de
UnitedHealth Group stock tracks earnings and cash flow - Ad-hoc-news.de
Judge throws out UnitedHealth’s defamation lawsuit against the Guardian - Star Tribune
UnitedHealth Defamation Suit Against The Guardian Investigative Report Dismissed - Yahoo Finance UK
Can UnitedHealth Group (NYSE:UNH) Regain Stability? - Kalkine Media
Mizuho raises UnitedHealth stock price target to $493 on earnings - Investing.com
UnitedHealth Group stock steadies as Medicare and Optum growth underpin recent earnings - Ad-hoc-news.de
BofA raises UnitedHealth stock price target to $512 on strong earnings - Investing.com
Finanzdaten der Unitedhealth Group Inc-Aktie (UNH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.80%
0.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):